Biotech/Healthcare are certainly seeing inflows of money from institutions. The RS on this name along with the clear volume accumulation is really nice. Potential consolidation into ATH Breakout.
Investor, Trader, Prolific Tweeter - Taking anything I say as advice wouldn’t be advisable. My opinions are probably someone else’s.